These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6418400)

  • 21. How can immunology contribute to the control of tuberculosis?
    Kaufmann SH
    Nat Rev Immunol; 2001 Oct; 1(1):20-30. PubMed ID: 11905811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New vaccines against tuberculosis.
    Mark Doherty T
    Trop Med Int Health; 2004 Jul; 9(7):818-26. PubMed ID: 15228493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monoclonal anti-tuberculosis antibodies react with DNA, and monoclonal anti-DNA autoantibodies react with Mycobacterium tuberculosis.
    Shoenfeld Y; Vilner Y; Coates AR; Rauch J; Lavie G; Shaul D; Pinkhas J
    Clin Exp Immunol; 1986 Nov; 66(2):255-61. PubMed ID: 3102132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New strategies against an old plague: genetically engineered tuberculosis vaccines.
    Dreher D; Kok M; Pechère JC; Nicod LP
    Schweiz Med Wochenschr; 2000 Dec; 130(50):1925-9. PubMed ID: 11189437
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Control of tuberculosis in relation to the HIV/AIDS epidemic. Work Group at the Secretariat of the National Plan on AIDS].
    Rev Esp Salud Publica; 1999; 73(5):533-47. PubMed ID: 10650745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The tuberculosis epidemic. Scientific challenges and opportunities.
    Ginsberg AM
    Public Health Rep; 1998; 113(2):128-36. PubMed ID: 9719813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Production and characteristics of monoclonal antibodies reacting with human-type M. tuberculosis].
    Chernousova LN; Kulikovskaia NV; Razumovskaia VS
    Probl Tuberk; 1990; (2):49-51. PubMed ID: 2111913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibody responses against Mycobacterium tuberculosis and production of monoclonal antibodies in mice.
    Ljungqvist L; Worsaae A; Heron I
    Acta Leprol; 1989; 7 Suppl 1():184-5. PubMed ID: 2503986
    [No Abstract]   [Full Text] [Related]  

  • 30. [Armenia: implementation of national program of malaria control].
    Grigorian G; Solkhomonian L
    Med Parazitol (Mosk); 2001; (1):21-4. PubMed ID: 11548307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of mutant mycobacteria as new vaccines to prevent tuberculosis.
    Hernàndez Pando R; Aguilar LD; Infante E; Cataldi A; Bigi F; Martin C; Gicquel B
    Tuberculosis (Edinb); 2006; 86(3-4):203-10. PubMed ID: 16542875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The second Geneva Consensus: Recommendations for novel live TB vaccines.
    Walker KB; Brennan MJ; Ho MM; Eskola J; Thiry G; Sadoff J; Dobbelaer R; Grode L; Liu MA; Fruth U; Lambert PH
    Vaccine; 2010 Mar; 28(11):2259-70. PubMed ID: 20074686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How research can help control tuberculosis.
    Chaisson RE; Harrington M
    World Hosp Health Serv; 2010; 46(1):33-40. PubMed ID: 20614683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prokaryotic expression and monoclonal antibody preparation of Mycobacterium tuberculosis ferric uptake regulator B.
    Jiang H; Gao X; Li Y; Xu ZK; Wang LM; Bai XF; Yue Y
    APMIS; 2008 May; 116(5):372-81. PubMed ID: 18452427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perspectives for the control of tuberculosis.
    Rosen H; Horn D; Shaw A
    Ther Immunol; 1995 Apr; 2(2):105-13. PubMed ID: 8729881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Production and characterization of monoclonal antibodies to Mycobacterium tuberculosis, M. bovis (BCG) and M. leprae.
    Kolk AH; Ho ML; Klatser PR; Eggelte TA; Kuijper S; de Jonge S; van Leeuwen J
    Clin Exp Immunol; 1984 Dec; 58(3):511-21. PubMed ID: 6439449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monoclonal antibodies against beta-antigen of Mycobacterium tuberculosis and their interspecies reactivities.
    Paik TH; Makino M; Ito T
    Biken J; 1987 Jun; 30(2):53-9. PubMed ID: 2449891
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new vision for the study of benign prostate disease: the NIDDK Prostate Research Strategic Plan.
    Mullins C; Kaplan SA
    J Urol; 2009 Mar; 181(3):963-71. PubMed ID: 19150562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction of pathogenic mycobacteria with the host immune system.
    Houben EN; Nguyen L; Pieters J
    Curr Opin Microbiol; 2006 Feb; 9(1):76-85. PubMed ID: 16406837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Reform of Japan's NTP and its technical perspectives].
    Mori T
    Kekkaku; 2004 Oct; 79(10):587-604. PubMed ID: 15631111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.